Abstract
This manuscript has been withdrawn as it was submitted without full consent of all the authors.
Competing Interest Statement
JS, DL, are full-time employees of the Regeneron Genetics Center and receive salary and stock options as part of compensation. All other authors have no conflict of interest to disclose.
Funding Statement
No funding sources to disclose.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Proband 1 and her parents consented for research genomic studies through an institutional research study approved by the Rambam Helsinki Committee, study number 0038-14-RMB. DiscovEHR participants were consented in accordance with the Geisinger Health System (GHS) Institutional Review Board approved protocol, study number 2006-0258.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
